Synergy CHC Corp. - SNYR

Sector: Healthcare · Industry: Medicinal Chemicals & Botanical Products
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$2.408M
QoQ value delta ($000)
-$1.59M (-39.77%)
Implied price effect (QoQ)
-23.84%
Shares
Total shares
1,297,093
QoQ shares delta
-343,005 (-20.91%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SNYR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 14 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
GRATIA CAPITAL, LLC 1,032 555,000 0.77%
HEARTLAND ADVISORS INC 1,023 550,000 0.06%
VANGUARD GROUP INC 176 95,107 0.0%
GEODE CAPITAL MANAGEMENT, LLC 67 36,038 0.0%
DRW Securities, LLC 36 19,487 0.0%
CITADEL ADVISORS LLC 25 13,809 0.0%
Warberg Asset Management LLC 25 13,675 0.0%
JANE STREET GROUP, LLC 19 10,464 0.0%
BANK OF AMERICA CORP /DE/ 2 1,544 0.0%
UBS Group AG 2 1,198 0.0%
Tower Research Capital LLC (TRC) 1 722 0.0%
Clearstead Advisors, LLC 0 49 0.0%